
Prof. Tom Eisenmann - "Why Startups Fail"
Violet Tumo
Paglalarawan
<p align="left"><span style="color: #e67e23;"><strong>Sal's Investment Syndicate:</strong></span> <strong><a href= "https://www.angelinvestboston.com/our-syndicates">Click to Join</a></strong></p> <p align="left">Harvard’s Tom Eisenmann is the author of <em>Why Startups Fail: A New Roadmap for Entrepreneurial Success</em>. We discussed valuable lessons from the book and how they might apply to biotech startups.</p> <p align="left">Highlights:</p> <ul> <li>Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of <em>Why Startups Fail</em></li> <li>Howard Stevenson’s 400X Return</li> <li>Contrasting Brad Feld’s Book with Prof. Tom Eisenmann’s Book</li> <li>Sal Daher’s Favorite Part of the Book: Failing</li> <li>“[failed] founders probably cycle through those. ...the Kubler Ross stages...”</li> <li>“...basically, half of failed founders come back and get back on the horse and do it again.”</li> <li>Shutting Down the Failed Venture, Gracefully</li> <li>The Number One Killer of Startups: False Starts</li> <li>“...engineers are particularly vulnerable to this because they want to build.”</li> <li>Sal Daher Discusses SQZ Biotech’s False Start and Brilliant Pivot</li> <li>The Origin Story of <em>Why Startups Fail</em></li> <li>“...the factories that actually make this stuff actually generate enough cash to invest in new apparel companies...”</li> <li>Silver Linings of the Pandemic</li> <li>Tom Eisenmann on Harvard’s School of Engineering and the MS/MBA Program</li> <li>Tom Eisenmann on Tough Tech: Technical Uncertainty + Market Uncertainty</li> <li>Creating Supports for Life Science Academics to Become Founders</li> <li>Creative Destruction Labs</li> <li>Sal Daher’s Focus on Biotech Angel Formation</li> <li>Software Startup Funding vs. Biotech Startup Funding</li> <li>Maybe Successful Angel-Backed Founders Such as Todd Zion and Armon Sharei Could be a Resource for Training Angels</li> <li>The Dynamics of Venture Capital in the Last Decade – Many New Shoots</li> <li>Tom Eisenmann’s Parting Though